objectives Human serum protein profiling of the individual infected with multiple dengue virus serotypes for identifying the potential biomarkers and to investigate the cause for the severity of dengue virus infection.
Introduction
Dengue virus belongs to the family Flaviviridae within the genus Flavivirus that causes high mortality and morbidity. Dengue fever is a mosquito-borne viral disease, causing 100 million infections annually and 25 000 deaths mostly among children [1] and [2] . The global incidence of dengue cases is significantly increasing every year and becoming a major threat to the mankind. As per World Health Organization (WHO), there were 390 million cases of dengue fever reported worldwide [3] , of which 100 million require proper medication. Dengue viral infection is caused by four distinct serotypes DENV-1, DENV-2, DENV-3 and DENV-4, which are varying antigenically in the envelope protein of the virus [4] . The capital city of India becomes the hot spot for dengue virus due to the climatic conditions favourable for Aedes mosquitoes breeding [5] .
A spectrum of clinical manifestations is associated with dengue infection such as high fever, joint pains, headache, febrile illness, nausea, vomiting and characteristic skin rashes that can last up to a 4-7 days. During the secondary infection, dengue fever progresses to severe dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) [6] . Dengue virus enters into the host cell by direct fusion with the cell membrane or by endocytosis [7] . Upon internalisation of the viral particle, the positive-strand RNA genome gets released into the cytoplasm, where the RNA gets translated. In humans, the immunity developed by any one of dengue serotype can potentially sensitise the individual to severe manifestation by exposure to a heterologous serotype [8] . The individual having DHF is characterised by severe bleeding, blood plasma leakage and an exceptionally low platelet count. However, DSS occurs due to low blood pressure, which may lead to a circulatory collapse (shock). The available diagnosis of dengue is based on non-structural protein (NS1) detection in the serum samples of an infected individual. The secretary NS1 can be detectable only in the early viremic phase of dengue infection, which cannot predict the severity of dengue infection [1] . Therefore, there is a need to discover a potential serum biomarkers, which can help in predicting the severity of dengue multiple infections [9] and [10] .
In this context, human serum samples derived from individuals infected with multiple dengue virus serotypes underwent proteomic analysis employing 2DGE and MALDI-TOF mass spectrometric analytical techniques. This study has a tremendous potential to provide information regarding biomarker identification, host-pathogen interactions and to evolve strategies to curb the severe dengue manifestations.
Materials and methods
Human blood samples were collected (as per WHO guidelines) from suspected dengue patients based on clinical symptoms of high fever, joint pains, headache and febrile illness. The Institute of Applied Dermatology (IAD), Kasaragod district, Kerala, gave ethical consent for conducting this study. Prior informed consent was obtained from all human participants. In total, 126 blood samples were collected from individuals showing clinical symptoms. The serum was separated from blood (2 ml) by centrifugation at 3000 g for 10 min in a microfuge tube. Blood sample collection, serum separation and processing were performed as per the description [11] .
Detection of dengue virus NS1 antigen by ELISA
The presence of dengue virus NS1 antigen in the patient serum samples was screened using a dengue-specific NS1 antigen detection enzyme-linked immunosorbent assay (ELISA) kit (Jmitra and Co., New Delhi, India) as per the manufacturer's instructions.
Molecular serotyping
Dengue NS1-positive samples were segregated based on molecular characterisation of the viral samples by reverse-transcriptase PCR (RT-PCR) followed by sero-specific PCR [12] .
Serum proteomic analysis
Based on the molecular serotyping, the serum samples were pooled into two groups, representing two different dengue serotypes co-infected (S2) and three different serotypes co-infected (S3) samples. The normal serum obtained from healthy individuals was pooled into control group (S1). Age-and sex-matched samples (n = 6) were pooled in each group for the analysis.
Serum albumin and IgGs were depleted from the pooled samples S1, S2 and S3 by HiTrap albumin & IgG depletion columns (Product 28-9480-20, GE Health Care life sciences,Hyderabad, India) as per the manufacturer's instructions. The protein content in eluted fractions was estimated by bicinchoninic acid (BCA) assay (Pierce chemical co., Rockford, USA) before loading on 2DGE.
In the first dimension of 2DGE, 300 microgram of protein sample from each group was loaded independently on IPG strips (3-10 pH, 18 cm immobilised pH gradient) kept for isoelectric focussing (IEF) for 14-16 h. IEF was performed on an Ettan IPGphor 3 isoelectric focussing unit (GE Healthcare) using the following voltage settings: 200 V for 4 h (step and hold), 500 V for 1 h (step and hold), 1000 V for 1 h (step and hold), 8000 V for 3 h (gradient) and 8000 V for 7:30 h (step and hold). After the IEF run, the strip was equilibrated in buffer containing 6 M urea, 75 mM Tris-HCl pH 8.8, 29.3% (v/v) glycerol, 2% (w/v) SDS and 0.002% (w/v) bromophenol blue, 1% (w/v) dithiothreitol (DTT) to reduce and alkylate the proteins.
The second dimension was carried out on 10% SDSpolyacrylamide gels in an Ettan DALTsix electrophoresis unit (GE Healthcare). The gels were stained with coomassie dye. The gel images were scanned using Epson Expression 11000XL Photo scanner. The comparative analysis of relative quantification across dengue multiple infected and control samples was carried out using ImageMaster 2D Platinum7, showing the differential expression of the protein spots (GE Healthcare). The gel images were imported to the software and subjected to comparative analysis for relative protein quantification across S1, S2 and S3 groups. Matched protein spots exhibiting differential expression with reproducibility and statistical significance (P ≤ 0.05) were selected and excised for further analysis. Scatter plots were made between the groups of S1 vs. S2 and S1 vs. S3.
The identified protein spots were sliced from the 2DGE gels, cut into small pieces and placed in fresh microfuge tubes. The gel pieces were destained for 10 min with 3-4 intervals using destaining solution. The gels were dehydrated using acetonitrile and completely dried under speedVac concentrator. The gel pieces were rehydrated with DTT by incubating for 1 h. After incubation, the upper solution was removed and gel pieces were incubated with Iodoacetamide for 45 min. The supernatant was removed, and the gel was incubated with ammonium bicarbonate solution for 10 min. The supernatant was removed, and the gel was dehydrated with acetonitrile for another 10 min and completely dried under speedVac concentrator. Trypsin solution was added to the tube and incubated overnight at 37°C. The digested solution was transferred to fresh microfuge tube. The gel pieces were extracted thrice with extraction buffer, and the supernatant was collected each time into the separate microfuge tube followed by air drying.
The mass of dried peptide mix was analysed by matrixassisted laser desorption-ionisation time-of-flight (MALDI-TOF) mass spectrometry (Bruker Daltonics ULTRAFLEX III). After trypsin digestion, the dried peptide mix was resuspended in Tris acetate (TA) buffer followed by mixing with a -cyano-4-hydroxycinnamic acid (CHCA, MW189.04 Da) matrix in sample to matrix ratio of 1:10. The resulting two microlitres was spotted onto the MALDI target plate. Further analysis was continued with Flex Analysis software for obtaining the Peptide Mass Fingerprint (PMF) of individual peptide fragments. The resulting peptide masses were submitted to MASCOT (version 2.1) (http://www.martixscience.com) search engine against NCBI, Swiss-Prot database for identification of the proteins. Identified proteins having at least two unique matched peptides were selected for consideration.
Validation of apolipoprotein A-1(APO A-1) by quantitative ELISA
We analysed the presence of APO A-1 independently, in the dengue serum samples infected with the multiple serotypes along with the single serotype-infected samples and compared with the age-and sex-matched normal serum samples (n = 6) as control. The analysis was carried out by quantitative ELISA (Elabsciences) as per the manufacturer's instructions. Unknown concentrations (mg/dl) of APO A-1 were calculated by plotting standard curve and regression analysis. The bar diagram was made by plotting the mean concentration of APO A-1 on Y-axis and test groups on X-axis. The statistical analysis was carried out using a GraphPad prism software.
Results

Dengue NS1 antigen detection and molecular serotyping show multiple infections
The presence of dengue NS1 antigen was tested by ELISA as mentioned in the methods section indicating the possibility of finding dengue genome. Of 100 cases of NS1-positive samples, 26 cases contained dengue genome as evidenced by the PCR amplification. Further, the dengue genome was subjected to molecular serotyping using sero-specific nested PCR. The results indicate the presence of multiple infections. A representative agarose gel image of nested PCR amplification showing the infection with two different serotypes (DENV 2 and 4) and three different serotypes (1, 2 and 4) is given in Figure 1a ,b, respectively.
Dengue multiple infection alters protein profile in the 2DGE
The samples infected with multiple dengue virus serotypes were pooled and grouped into S2 and S3 as detailed above along with a pooled control group (S1). Albumin and immunoglobulins (IgG) were depleted from serum and subjected to 2DGE, and the results indicated that there was a modulation in the expression of serum proteins in the infected sample as compared to control group (S1); 298 and 311 protein spots were identified in S2 and S3 groups, respectively. The coomassie-stained gels showed the protein spots as shown in Figure 2 .
There were 42 and 51 matched protein spots in S1 vs. S2 and S1 vs. S3 groups, respectively, exhibiting differential expression with reproducibility and statistical significance (P ≤ 0.05) as shown in Figure 3 with scatter plot analysis as shown in Figure 4 . There were seven upregulated proteins and six downregulated proteins found in S1 vs. S2 groups. The upregulation was calculated based on fold increase that varied from twofold to 13-fold. Similarly, there were six upregulated proteins and 13 downregulated proteins found in S1 vs. S3 groups. The upregulation varied from twofold to sevenfold.
Multiple dengue serotypic infection upregulates apolipoprotein A-1 (APO A-1)
The upregulated protein spots from the 2DGE analysis were considered for further investigation. Based on MALDI-TOF followed by MASCOT search engine, the upregulated proteins identified in S2 and S3 groups in comparison with the healthy control group S1 (P < 0.05) are given in Table 1 . Interestingly, it is evidence from the experiment that lipid-free APO A-1 is upregulated in both S2 and S3 groups. IDs common in healthy control group S1 and dengue virus-infected groups S2 and S3. Only 42 matched spots of protein were found in S1 vs. S2 and 51 matched spots of protein were found in S1 vs. S3 groups. The 3D images of statistically significant (P < 0.05) differentially expressed spots were analysed using Image Master 2D Platinum 7 soft ware.
Daltons as given in Figure 5 . Based on MASCOT results, the protein was identified as lipid-free apolipoprotein A-1 (Gene ID 90108664, Mass 28061 Da).
Validation of apolipoprotein A-1 (APO A-1) by quantitative ELISA
The levels of APO A-1 present in serum samples of dengue multiple infections were determined by quantitative ELISA as mentioned in methods section. There was an enhancement (P < 0.05) of APO A-1 concentrations in both two different serotypes (Group B) infected as well as three different serotypes infected samples (Group C) as compared to the control group. Also, it is evident that there is a significant (P < 0.05) enhancement in the level of APO A-1 in single serotypic infection (Group A) as compared to the control group. It is also important to note that there is a positive correlation between the number serotypes involved in the infection and the level of APO A-1 in the sample as shown in the Figure 6 .
Discussion
In this study, we investigated the human serum proteome changes occurred during multiple infections caused by different serotypes of dengue viruses. Based on the clinical symptoms, the blood samples were collected from dengue infected human individuals located in northern Kerala, India. The serum was separated from the blood, and the samples were pooled into two groups based on the sero-specific PCR results [12] as detailed in the methods. The pooled samples were subjected proteomic profiling using 2DGE MALDI-TOF. There were significant alterations in the protein expression profile in the serum samples derived from the individuals infected with multiple serotypes of dengue viruses as compared to the control group. Thirteen different serum proteins were upregulated by a factor >2 and significant threshold value (<0.05), as shown in Table 1 . These proteins include the following: chain A, crystal structure of complement C3b in complex with factors B and D, chain A (13-fold upregulation), Crig bound to C3c (11-fold upregulation), fibrin beta (eightfold upregulation), chain A, crystal structure of lipid-free human apolipoprotein A-1 (sevenfold upregulation). We tested the molecular functionality of the upregulated proteins and their correlation with dengue viral pathogenesis by PANTHER tool (Protein ANalysis THrough Evolutionary Relationships; http://pantherdb.org/about.jsp). The investigation revealed that the upregulated host serum proteins Figure 4 Scatter plots of proteins exhibiting altered expression levels on the two-dimensional gels. The scatter plots were plotted between the groups of a) S1 vs. S2 by taking the number of matched spots in S1 group on Y-axis and S2 group on X-axis. The total 42 matched protein spots were identified with correlation value of 0.7033; b) S1 vs. S3 by taking the number of matched spots in S1 groups on Y-axis and S3 groups on X-axis. The total 51 matched protein spots were identified with correlation value of 0.6694. In both panels of a and b, S1: Group containing the pooled serum of healthy individuals (n = 6), S2: Group containing the pooled serum of two dengue serotypes co-infected samples (n = 6), S3: Group containing the pooled serum of three dengue serotypes co-infected samples (n = 6).
are involved in activation of the complement cascades, immune response, cell mediated signalling, lipid metabolism, blood coagulation, inflammatory-mediated cellular functions (data not shown). It has been reported that a complementary pathway is activated during infection and dengue virus NS1 protein helps in the immune evasion from the complementary pathway [13] . However, in cases of severe dengue disease manifestations, the secreted NS1 antigen in the presence of pre-existing, non-neutralising, heterologous antibody may mediate complement activation and trigger plasma leakage [14] . As the current study was carried out in the NS1-positive serum sample, the upregulated proteins that are related to the complement pathway may be specifically involved in the initial phase of dengue infection.
It is important to note that the lipid-free human apolipoprotein A-1 (APO A-1) (accession number 90108664) upregulated more than sevenfold in both cases of heterotypic infection involving two as well as three different serotypes (Table 1) . Antiparallel APO A-1 is paired by their C-terminal alpha-helices, known to be important for lipid binding and maintenance of high-density lipids (HDL) in circulation, which is also involved in the interaction of lipid-free APO A-1 with macrophages and specific lipid efflux [15] . HDL is functionally important in the process of virus infection. Apo A-1 facilitates dengue virus attachment and enhances dengue virus (DV) infection by binding to the virus envelope glycoproteins [7] .
The proteomic data were further validated by analysing the level of APO A-1 by quantitative ELISA in the individual serum samples. All samples infected with dengue virus showed significant (P < 0.05) enhancement of APO A-1 as compared to the control group. Interestingly, we In all cases, significance threshold P value (t-test) is <0.05. S1: Group containing the pooled serum of healthy individuals, S2: Group containing the pooled serum of two dengue serotypes co-infected samples, S3: Group containing the pooled serum of three dengue serotypes co-infected samples. The GenBank accession numbers are from National Center for Biotechnology Information (NCBI). The row containing APO A-1 is highlighted.
observed a positive correlation between the level of APO A-1 and number of serotypes of dengue infected the individual. A single serotype-infected sample showed lowest level of APO A-1 as compared to the multiple serotypic infection. There are previous reports [11] and [16] on serum proteome profiling of dengue virus-infected patients yet none of them profiled serum containing dengue multiserotypes. To best of our knowledge, this is the first report on serum proteome analysis of dengue multiple serotypic infection. Mostly, the lipoproteins will provide immune defence to the virus to escape from the host immune system [17] and [18] . In the host cell, APO A-1 exists either in a lipidated or self-associated lipid-free form [19] and [20] . There are reports indicating the reduction in the serum level of HDL and LDL in patients, which is correlated with severe dengue symptoms [21] . This supports the hypothesis that the ApoA1 may exist in the lipid-free form in the dengue patients and which gets complexed with the viral particle and helps in the entry into host cells containing ApoA1 receptors, as evidenced in the previous cellular studies [7] . APO A-1 a major component of HDL has a role in lipid absorption, transport and metabolism [22] . Also, apolipoprotein of HDL protects the platelet thrombolytic accumulation at sites of vascular damage [23] during infection. PPAR alpha activation increases plasma HDL cholesterol via the induction of hepatic apolipoprotein A-I and apolipoprotein A-II expression in humans [24] . Our results indicate that APO A-1 exists in lipid-free form in the serum of dengue viral Figure 5 The MALDI mass spectra of lipid-free apolipoprotein A-1 (Gene ID: 90108664, Mass:28061 Da). Representative MALDI mass spectra of lipid-free apolipoprotein A-1 upregulated(>7fold) in S2 group. In the graph, X-axis represents mass/charge (m/z) ratio and Y-axis represents intensities (a.u) 910
4
. On right-hand side of the spectra, m/z ratio, signal to noise (S/N) ratio, quality factor, resolution, intensities and area of each fragment are shown. S2: Group containing the pooled serum of two dengue serotypes co-infected samples (n = 6). multiple infections. There is a possibility that APO A-1 will associate with dengue NS1 antigen and thereby help in its secretion into the blood stream. Elevated APO A-1 level may be a risk factor for a first haemorrhagic stroke [25] and [26] . Dengue virus infectivity was enhanced when virus is pre-incubated with lipid-free form of APO A-1, which implicates that the dengue virus has direct interaction with lipid-free APO A-1 [7] . As per the existing literature, it could be hypothesised that ApoA1 facilitates the infection through scavenger receptor class B type I (SR-B1) receptors present on the host cells as evidenced by the previous cellular studies [7] . It is tempting to hypothesise that APO A-1 may play a significant role in the enhancement of dengue virus uptake into the immune cells during dengue multiple infections leading to the severity of dengue. ApoA-I would facilitate or cause increased uptake of dengue virus by binding to SR-BI and contributes to disease development. The active role of apo A-1 in dengue virus entry mediated through complex interplay between SR-B1, HDL and dengue virus envelope glycoproteins needs to be studied in detail. Therefore, APO A-1 can be subjected for further investigation as a biomarker for predicting multiple serotypic infections of dengue virus and severity of dengue manifestations. 
